13-cis-RA	13-cis-retinoic acid
ADA	anti-drug antibody
BM	bone marrow
BuMEL	busulfan and melphalan
CEM	carboplatin, etoposide, and melphalan
CI	confidence interval
COJEC	cisplatin, vincristine, carboplatin, etoposide, and cyclophosphamide
CT	computed tomography
DB	dinutuximab beta
EFS	event-free survival
EOT	end of treatment
FAS	full analysis set
HR	hazard ratio
IL-2	interleukin-2
INSS	International Neuroblastoma Staging System
IPD	individual patient data
IPSW	inverse probability of selection weights
IQR	interquartile range
LDH	lactate dehydrogenase
MIBG	metaiodobenzylguanidine
MRI	magnetic resonance imaging
OS	overall survival
PS	propensity score
RA	13-cis-retinoic acid (isotretinoin)
R/R	relapsed or refractory
SA	sensitivity analysis/analyses
SD	standard deviation